Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-11-12
1996-06-04
Knode, Marian C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 536 21, 536 20, 4352402, 43524021, 4352403, A61K 3816, A61K 3800, C08B 3710, C08B 3708, C12N 500
Patent
active
055232868
ABSTRACT:
An anionic macromolecular containing composition is disclosed that is capable of supporting conservation and differentiation of long-term bone marrow culture initiating cells in cultured mammalian hematopoietic cells. The composition disclosed is a mixture of glycoproteins, more specifically proteoglycans, which are of a molecular weight greater than 200 kD.
REFERENCES:
J. Brandt et al., Blood, 79, 634 (1992) is cited in the specification at p. 6, line 20.
J. Brandt et al., J. Clin. Invest., 82, 1017 (1988) is cited in the specification at p. 6, line 8.
J. Brandt et al., J. Clin. Invest., 86, 932 (1990) is cited in the specification at p. 5, line 21 and at p. 6, line 25.
J. Caldwell et al., J. Cell Physiol., 147, 344 (1991) is cited in the specification at p. 6, line 36.
T. M. Dexter et al., J. Cell Physiol., 91, 335 (1977) is cited in the specification at p. 3, line 30.
C. J. Eaves et al., Blood, 78, 110 (1991) is cited in the specification at p. 5, line 16.
F. A. Fletcher et al., Blood, 76, 1098 (1990) is cited in the specification at p. 6, line 16.
S. Gartner et al., PNAS USA, 77, 4756 (1980) is cited in the specification at p. 4, line 8.
M. Y. Gordon et al., J. Cell. Physiol., 130, 150 (1987) is cited in the specification at p. 4, line 16.
D. N. Haylock et al., Blood, 80, 1405 (1992) is cited in the specification at p. 5, line 24.
S. Huang et al., Nature, 360, 745 (1992) is cited at the specification at p. 6, line 23.
K. Ikebuchi et al., PNAS USA, 85, 3445 (1988) is cited at the specification at p. 6, line 6.
E. L. W. Kittler et al., Blood, 79, 3168 (1992) is cited in the specification at p. 5, line 15 and at p. 6, line 37.
A. G. Leary et al., Blood, 71, 1759 (1988) is cited in the specification at p. 6, line 9.
G. Migliascio et al., Blood, 79, 2620 (1992) is cited in the specification at p. 5, line 23.
S. R. Paul et al., PNAS USA, 87, 7512 (1990) is cited in the specification at p. 4, line 12.
F. T. Slovick et al., Exp. Hematol., 12, 327 (1984) is cited in the specification at p. 4, line 9.
L. W. M. M. Terstappenet et al., Blood, 77, 1218 (1991) is cited in the specification at p. 5, line 22.
K. Tsuji et al., Blood, 79, 2855 (1992) is cited in the specification at p. 6, line 13.
C. M. Verfaillie, Blood, 79, 2821 (1992) is cited in the specification at p. 4.
C. M. Verfaillie et al., J. Exp. Med., 172, 509 (1990) is cited in the specification at p. 2, line 33; at p. 8, line 1; at p. 13, line 28 at p. 16, line 24; at p. 17, line 5; and at p. 18, lines 4, 7, 15 and 17.
K. M. Zsebo et al., Cell, 63, 195 (1990) is cited in the specification at p. 6, line 21.
Suzu et al, J. Biol. Chem., 267(24), pp. 16812-16815 (Aug. 25, 1992).
Suzu et al., J. Biol. Chem. 267(7), pp. 4345-4348 (Mar. 5, 1992).
Oppenheim et al, "Immunophysiology--The Role of Cells & Cytokines in Immunity & Inflammation" published by 1990 by Oxford Press (NY), pp. 166-193.
McGlave Philip B.
Verfaillie Catherine M.
Dadio Susan M.
Knode Marian C.
Regents of the University of Minnesota
LandOfFree
Stroma-derived proteoglycan containing composition which promote does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stroma-derived proteoglycan containing composition which promote, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stroma-derived proteoglycan containing composition which promote will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-383339